IMV Inc.  Banner Image

IMV Inc. has reached its limit for free report views

Work for IMV Inc. ? Upgrade Your Profile and unlock all your annual reports.

IMV Inc.

  • Ticker IMV
    Exchange TSX More
  • Industry Biotechnology More
  • Sector Healthcare More
IMV Inc.  Logo Image
  • 51-200 Employees
  • Based in Dartmouth, Nova Scotia
IMV Inc. is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV's proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. Lead product candidateMore DPX-Survivac is currently being evaluated in several clinical trials in advanced ovarian cancer in combination with other innovative immunotherapy agents.
IMV Inc.

Most Recent Annual Report

IMV Inc. MOST RECENT 2019 Annual Report

Report Locked. IMV Inc. has reached its limit for free report views.

Older/Archived Annual Reports